Jon B. Chick

Family Medicine
7545 Beechmont Ave Ste C
Cincinnati, OH 45255

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

First-in-human phase I trial of two schedules of OSI-930, a novel multikinase inhibitor, incorporating translational proof-of-mechanism studies.

First-in-human phase I trial of two schedules of OSI-930, a novel multikinase inhibitor, incorporating translational proof-of-mechanism studies.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 14, 2013
Showing 1-1 of 1

Last Updated: 09/26/2026